RenovoRx, Inc. (RNXT)
1.14
-0.05
(-4.20%)
USD |
NASDAQ |
Oct 16, 16:00
1.15
+0.01
(+0.88%)
After-Hours: 20:00
RenovoRx Cash and Short Term Investments (Quarterly) : 9.479M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.479M |
| March 31, 2026 | 12.36M |
| December 31, 2025 | 7.024M |
| September 30, 2025 | 10.04M |
| June 30, 2025 | 12.31M |
| March 31, 2025 | 14.58M |
| December 31, 2024 | 7.154M |
| September 30, 2024 | 9.563M |
| June 30, 2024 | 11.74M |
| March 31, 2024 | 4.389M |
| December 31, 2023 | 1.173M |
| Date | Value |
|---|---|
| September 30, 2023 | 3.226M |
| June 30, 2023 | 5.954M |
| March 31, 2023 | 3.723M |
| December 31, 2022 | 6.44M |
| September 30, 2022 | 8.114M |
| June 30, 2022 | 10.76M |
| March 31, 2022 | 13.12M |
| December 31, 2021 | 15.19M |
| September 30, 2021 | 17.72M |
| June 30, 2021 | 1.557M |
| March 31, 2021 | 0.837M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Enanta Pharmaceuticals, Inc. | 189.51M |
| Travere Therapeutics, Inc. | 489.18M |
| REGENXBIO, Inc. | 105.74M |
| Krystal Biotech, Inc. | 845.63M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |